Industry Events
EnglishFrançaisEspañol中文العربية
EventsNewsInsightsOrganisers
Services
  • Event MarketingList, promote and grow your events to a global B2B audience.
  • Press ReleaseDistribute official announcements to industry professionals worldwide.
  • Speaker & SME PromotionShowcase expertise, get booked for keynotes, panels and masterclasses.
Subscribe
Speaker Sign InList Your Free Event
Industry Events

The world's most trusted B2B event discovery platform. Connecting industry professionals with the conferences, expos and summits that matter.

Explore & Services
  • Industry Events
  • News
  • Event Organisers
  • About Us
  • Our Services
  • Premium Organiser
  • Event Pro
  • Become a Speaker
  • Subscribe
Legal & Privacy
  • Terms
  • Privacy

© 2026 Industry Events Worldwide. All rights reserved.

VF103.4.
Industry Events

The world's most trusted B2B event discovery platform. Connecting industry professionals with the conferences, expos and summits that matter.

  • Industry Events
  • News
  • Event Organisers
  • About Us
  • Our Services
  • Premium Organiser
  • Event Pro
  • Become a Speaker
  • Subscribe
  • Terms
  • Privacy

© 2026 Industry Events Worldwide. All rights reserved.

VF103.4.
  • Events
  • News
  • Insights
  • Account
Industry Events
EnglishFrançaisEspañol中文العربية
EventsNewsInsightsOrganisers
Services
  • Event MarketingList, promote and grow your events to a global B2B audience.
  • Press ReleaseDistribute official announcements to industry professionals worldwide.
  • Speaker & SME PromotionShowcase expertise, get booked for keynotes, panels and masterclasses.
Subscribe
Speaker Sign InList Your Free Event
  1. Home
  2. News
  3. STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching

STAT News

STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching

Roivant's autoimmune drug approval, Cytokinetics reports full data for heart condition treatment, and more biotech news

Continue with the complete report on the publisher’s website.

Read full article at STAT News
S

By STAT News

28 August 2026|1 min read
Share
Health Tech
STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching
STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching
Share
← Back to IE News

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

  • STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation

    STAT News

    STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation

    7 September 2026
  • STAT+: Seattle scientists launch $95 million AI biology effort

    STAT News

    STAT+: Seattle scientists launch $95 million AI biology effort

    3 September 2026
  • Opinion: The FDA removed the red tape around one of the best drugs for children with schizophrenia. But the fear remains

    STAT News

    Opinion: The FDA removed the red tape around one of the best drugs for children with schizophrenia. But the fear remains

    4 September 2026
  • STAT+: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more

    STAT News

    STAT+: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more

    4 September 2026
  • ‘Tactical athletes’ get new guidance for cardiovascular fitness

    STAT News

    ‘Tactical athletes’ get new guidance for cardiovascular fitness

    3 September 2026
  • Opinion: Make infectious disease data boring again

    STAT News

    Opinion: Make infectious disease data boring again

    4 September 2026

Related Insights

  • The Bio Revolution Is Here — And the World Is Already Choosing Sides

    Biology is becoming the next great industrial platform — accelerated by AI, contested by China and the US, and creating tomorrow's careers.

    8 Sept 202613 min read
  • Quantum computing

    The race to master quantum computing could reshape medicine, energy and security.

    8 Sept 202623 min read
  • Workforce transformation and the future of skills

    10 cross-sector shifts creating the next business opportunities

    The biggest business opportunities of the next decade may not sit inside AI, energy, space, telecoms or manufacturing individually; they are emerging where growth in one sector creates a bottleneck—and therefore a market—in another.

    7 Sept 202610 min read
Browse all insights →

Related Events

  • Project Finance & Project Financial Modelling - Oct 2026

    19 Oct 2025
  • Autonomous e-Mobility Forum 2026

    7 Sept 2026
    Qatar
  • 3rd Government Digital Transformation Summit

    7 Sept 2026
    Riyadh, Saudi Arabia
  • AeroTech Vietnam 2026

    8 Sept 2026
    Hanoi, Vietnam
Browse All Events→

More From The Newsroom

  • STAT+: Fauci speaks, and writes

    STAT+: Fauci speaks, and writes

    3 September 2026
  • STAT+: FDA takes another look at botanical drugs

    STAT+: FDA takes another look at botanical drugs

    4 September 2026
  • HHS flip-flops on disability lawsuit

    HHS flip-flops on disability lawsuit

    3 September 2026
  • STAT+: Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder

    STAT+: Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder

    3 September 2026
Industry Events

The world's most trusted B2B event discovery platform. Connecting industry professionals with the conferences, expos and summits that matter.

Explore & Services
  • Industry Events
  • News
  • Event Organisers
  • About Us
  • Our Services
  • Premium Organiser
  • Event Pro
  • Become a Speaker
  • Subscribe
Legal & Privacy
  • Terms
  • Privacy

© 2026 Industry Events Worldwide. All rights reserved.

VF103.4.
Industry Events

The world's most trusted B2B event discovery platform. Connecting industry professionals with the conferences, expos and summits that matter.

  • Industry Events
  • News
  • Event Organisers
  • About Us
  • Our Services
  • Premium Organiser
  • Event Pro
  • Become a Speaker
  • Subscribe
  • Terms
  • Privacy

© 2026 Industry Events Worldwide. All rights reserved.

VF103.4.